
Inogen INGN
$ 6.59
6.29%
Annual report 2025
added 02-27-2026
Inogen Accounts Payables 2011-2026 | INGN
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.3 M | 16.6 M | 13.5 M | 18.2 M | 10.3 M | 12.5 M | 16.4 M | 13.7 M | 9.54 M | 5.74 M | 7.45 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.3 M | 5.74 M | 13.1 M |
Quarterly Accounts Payables Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.2 M | 21.9 M | 23.3 M | 16.6 M | 15.5 M | 15 M | 15.9 M | 13.5 M | 15.4 M | 13.4 M | 18 M | 18.2 M | 21.5 M | - | 18.1 M | 10.3 M | 15.9 M | 15.6 M | 14.6 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 9.54 M | 9.54 M | 9.54 M | 9.54 M | 5.74 M | 5.74 M | 5.74 M | 5.74 M | 7.45 M | 7.45 M | 7.45 M | 7.45 M | 6.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.3 M | 5.74 M | 13.3 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
109 M | $ 185.02 | -0.81 % | $ 13.9 B | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.58 | -0.55 % | $ 1.7 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 38.94 | -1.37 % | $ 5.8 K | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.59 | 1.99 % | $ 134 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 63.42 | -1.83 % | $ 93.9 B | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | 3.18 % | $ 38 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 10.5 | 0.38 % | $ 297 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
2.67 M | $ 25.39 | -1.24 % | $ 215 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 92.76 | -1.87 % | $ 12.5 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.06 | 6.19 % | $ 1.25 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 5.29 | 8.74 % | $ 1.12 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.04 | - | $ 17.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 16.53 | -7.39 % | $ 388 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 10.83 | -1.46 % | $ 388 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 56.45 | -0.34 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 37.91 | -3.88 % | $ 1.18 B | ||
|
LENSAR
LNSR
|
19 M | $ 5.8 | -7.2 % | $ 69.4 M | ||
|
LivaNova PLC
LIVN
|
97.2 M | $ 65.01 | -0.2 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 88.37 | 0.49 % | $ 3.07 B | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.76 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 79.05 | 1.09 % | $ 46.2 B | ||
|
Penumbra
PEN
|
34.7 M | $ 331.47 | -0.29 % | $ 12.9 B | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M |